Satoshi Ishido

7PUBLICATIONS
39CO-AUTHORS
Innate immunityPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)AllergyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 25, 2026
Development of a Self-Adjuvanting Influenza Peptide-Glycolipid Conjugate Inducing CD8+ T-Cell Immunity.

Shunya Kikuchi, Hideki Ogura, Takanori Matsumaru

|Sep 05, 2025
Identification of beneficial symbiont candidates in commensalism as potential oral gatekeepers.

Soutaro Hanawa, Aoi Son, Tamotsu Kato

|Sep 13, 2022
MARCH1 Controls an Exhaustion-like Program of Effector CD4+ T Cells Promoting Allergic Airway Inflammation.

Carlos A Castellanos, Kamir J Hiam-Galvez, Satoshi Ishido

|Feb 10, 2022
Marginal zone B cells acquire dendritic cell functions by trogocytosis.

Patrick Schriek, Alan C Ching, Nagaraj S Moily

|Oct 15, 2021
Lymph node-resident dendritic cells drive TH2 cell development involving MARCH1.

Carlos A Castellanos, Xin Ren, Steven Lomeli Gonzalez

Pageof 2